APOTEX FDA Approval ANDA 205876

ANDA 205876

APOTEX

FDA Drug Application

Application #205876

Application Sponsors

ANDA 205876APOTEX

Marketing Status

Prescription001

Application Products

001TABLET;ORAL-283MG;0.03MG0DROSPIRENONE AND ETHINYL ESTRADIOLDROSPIRENONE; ETHINYL ESTRADIOL

FDA Submissions

UNKNOWN; ORIG1AP2016-09-21STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

APOTEX
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 205876
            [companyName] => APOTEX
            [docInserts] => ["",""]
            [products] => [{"drugName":"DROSPIRENONE AND ETHINYL ESTRADIOL","activeIngredients":"DROSPIRENONE; ETHINYL ESTRADIOL","strength":"3MG;0.03MG","dosageForm":"TABLET;ORAL-28","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/21\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2016-09-21
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.